Cancer Stocks to Consider as Oncology Innovation Accelerates
Oncology stocks are gaining relevance as cancer care evolves, with Pfizer, Merit Medical Systems and Abbott advancing treatments, diagnostics and screening technologies.
MMSI - Merit Medical Systems, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$101.88
DETAILS
HIGH:
$114.00
LOW:
$94.00
MEDIAN:
$100.50
CONSENSUS:
$101.88
UPSIDE:
13.74%
Stock News
Merit Medical Systems to Announce Third Quarter 2026 Results on October 29, 2026
SOUTH JORDAN, Utah, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that it will release its financial results for the quarter ended September 30, 2026, after the close of the stock market on Thursday, October 29, 2026. Merit plans to hold its investor conference call on the same day (Thursday, October 29, 2026) at 4:30 p.m. Eastern (3:30 p.m. Central, 2:30 p.m. Mountain, and 1:30 p.m. Pacific).
HSIC or MMSI: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Henry Schein (HSIC) or Merit Medical (MMSI). But which of these two stocks presents investors with the better value opportunity right now?
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now
MMSI's broad product portfolio, global expansion and strategic M&A support growth, while tariffs and China pressures remain key risks.
5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve
Here, we highlight five medical supplies stocks, MCK, CAH, BDX, MMSI and PDEX, with strong potential that investors should keep on their watchlist amid improving industry prospects.
Financial Survey: Merit Medical Systems (NASDAQ:MMSI) vs. Bausch + Lomb (NYSE:BLCO)
Merit Medical Systems (NASDAQ: MMSI - Get Free Report) and Bausch + Lomb (NYSE: BLCO - Get Free Report) are both mid-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, institutional ownership and risk. Institutional and Insider Ownership 99.7%
Merit Medical to Participate in Upcoming Investors Conferences in September
SOUTH JORDAN, Utah, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that management is scheduled to participate in the following upcoming investor conferences:
27,531 Shares in Merit Medical Systems, Inc. $MMSI Bought by Jupiter Topco LLC
Jupiter Topco LLC bought a new position in shares of Merit Medical Systems, Inc. (NASDAQ: MMSI) during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 27,531 shares of the medical instruments supplier's stock, valued at approximately $1,908,000. Several other hedge
Hsbc Holdings PLC Invests $414,000 in Merit Medical Systems, Inc. $MMSI
Hsbc Holdings PLC purchased a new stake in shares of Merit Medical Systems, Inc. (NASDAQ: MMSI) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 5,983 shares of the medical instruments supplier's stock, valued at approximately $414,000. Several
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now
MMSI's broad portfolio, R&D investments and WRAPSODY opportunity support growth, while tariffs, China pressure and competition remain risks.
Freestone Grove Partners LP Purchases Shares of 16,554 Merit Medical Systems, Inc. $MMSI
Freestone Grove Partners LP purchased a new position in Merit Medical Systems, Inc. (NASDAQ: MMSI) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 16,554 shares of the medical instruments supplier's stock, valued at approximately $1,148,000. Other hedge funds and other
Oncology Stocks to Add to Your Portfolio as Cancer Care Evolves
Oncology innovation is driving new treatment options, with Iovance, Merit Medical and Kura advancing cancer-focused therapies and technologies.
American Capital Management Inc. Buys Shares of 104,967 Merit Medical Systems, Inc. $MMSI
American Capital Management Inc. acquired a new stake in Merit Medical Systems, Inc. (NASDAQ: MMSI) during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 104,967 shares of the medical instruments supplier's stock, valued at approximately $7,278,000. American Capital Management
Should You Buy MMSI as Growth Improves but Valuation Stays Elevated?
Merit Medical's growth case is strengthening as launches, acquisitions and therapeutic products broaden its mix, but its premium valuation raises the execution bar.
Can MMSI Sustain Its 22.2% Gain in the Past Month as Growth Improves?
Merit Medical's 22.2% monthly rally gains support from stronger Q2 growth and a raised 2026 outlook, but valuation and tariff risks remain.
COO vs. MMSI: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both The Cooper Companies (COO) and Merit Medical (MMSI). But which of these two stocks is more attractive to value investors?
Here's Why Merit Medical (MMSI) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Merit Medical Announces Global Operations Leadership Transition
SOUTH JORDAN, Utah, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer of healthcare technology, today announced that Sheri Lewis has agreed to join Merit as Executive Vice President of Global Operations, effective August 31, 2026.
Merit Medical Eyes Next Growth Plan as Margins, Portfolio Review Take Center Stage
Merit Medical Systems (NASDAQ: MMSI) is focused on completing the objectives of its current long-range plan while developing its next strategic framework, Chief Financial Officer and Treasurer Raul Parra said during a Canaccord investor event. Parra said the company remains "hyper-focused" on executing its current CGI plan and does not want to "drop the football on
Merit Medical Eyes Next Growth Plan as Margins, Portfolio Review Take Center Stage
Merit Medical Systems NASDAQ: MMSI is focused on completing the objectives of its current long-range plan while developing its next strategic framework, Chief Financial Officer and Treasurer Raul Parra said during a Canaccord investor event.
Price Targets
Merit Medical price target raised to $114 from $107 at Barrington
$114.00
(was $84.22)
Michael Petusky
·
Barrington
Merit Medical Systems, Inc. (MMSI) PT Raised to $94 at Canaccord
$94.00
(was $84.42)
John Young
·
Canaccord Genuity
Merit Medical price target raised to $100 from $83 at Raymond James
$100.00
(was $84.06)
Raymond James
Merit Medical price target raised to $105 from $100 at BTIG
$105.00
(was $84.27)
Sam Eiber
·
BTIG
Merit Medical Systems, Inc. (MMSI) PT Raised to $101 at Needham
$101.00
(was $83.35)
Mike Matson
·
Needham
Merit Medical price target raised to $98 from $89 at Baird
$98.00
(was $83.35)
Robert W. Baird
Merit Medical price target lowered to $83 from $92 at Baird
$83.00
(was $64.61)
David Rescott
·
Robert W. Baird
Merit Medical price target lowered to $107 from $109 at Barrington
$107.00
(was $70.93)
Michael Petusky
·
Compass Point
Merit Medical price target lowered to $96 from $106 at Piper Sandler
$96.00
(was $70.10)
Piper Sandler
Wells Fargo Downgrades Merit Medical Systems, Inc. (MMSI) to Equal Weight
$78.00
(was $79.23)
Larry Biegelsen
·
Wells Fargo
Merit Medical price target lowered to $106 from $113 at Piper Sandler
$106.00
(was $81.59)
Piper Sandler
Merit Medical initiated with a Buy at BTIG
$107.00
(was $79.63)
BTIG
Merit Medical price target raised to $99 from $93 at Canaccord
$99.00
(was $86.85)
Canaccord Genuity
Merit Medical price target raised to $108 from $103 at Baird
$108.00
(was $86.41)
David Rescott
·
Robert W. Baird
Merit Medical price target raised to $106 from $103 at Barrington
$106.00
(was $88.98)
Barrington
Merit Medical price target raised to $103 from $102 at Baird
$103.00
(was $86.16)
David Rescott
·
Robert W. Baird
Merit Medical price target raised to $104 from $103 at Canaccord
$104.00
(was $80.47)
John Young
·
Canaccord Genuity
Merit Medical price target raised to $112 from $108 at Canaccord
$112.00
(was $96.49)
John Young
·
Canaccord Genuity
Merit Medical price target lowered to $103 from $111 at Barrington
$103.00
(was $93.86)
Michael Petusky
·
Barrington
Merit Medical price target lowered to $110 from $111 at Baird
$110.00
(was $94.61)
David Rescott
·
Robert W. Baird